Literature DB >> 25357252

Comparing medication attitudes and reasons for medication nonadherence among three disparate groups of individuals with serious mental illness.

Jennifer B Levin1, Nasim Seifi, Kristin A Cassidy, Curtis Tatsuoka, Johnny Sams, Kouri K Akagi, Martha Sajatovic.   

Abstract

This analysis compared medication attitudes and reasons for nonadherence in three distinct groups of patients with serious mental illness (SMI). Cohort 1 had 43 patients with bipolar disorder (BD) treated in a community mental health setting, cohort 2 had 43 patients with BD taking an atypical antipsychotic and treated in an academic medical center, and cohort 3 had 30 patients with schizophrenia or schizoaffective disorder who had been homeless in the last year. Standardized attitudinal scales found generally negative attitudes toward medication and limited illness insight. Although the three cohorts differed with regard to severity of symptoms, age of onset, education, baseline adherence, and race, the groups had similar medication attitudes before and after treatment. Despite group differences in demographic and clinical variables, our analyses found more similarities than differences in medication attitudes among these three discrete groups of poorly adherent, symptomatic patients with SMI. The common attitudinal characteristics have implications for delivery of health care services that can enhance treatment adherence in high-risk SMI patients.

Entities:  

Mesh:

Year:  2014        PMID: 25357252      PMCID: PMC4215200          DOI: 10.1097/NMD.0000000000000201

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  19 in total

1.  Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder.

Authors:  Robert M Post; Lori L Altshuler; Mark A Frye; Trisha Suppes; Paul E Keck; Susan L McElroy; Gabriele S Leverich; David A Luckenbaugh; Michael Rowe; Scott Pizzarello; Ralph W Kupka; Heinz Grunze; Willem A Nolen
Journal:  J Clin Psychiatry       Date:  2010-09       Impact factor: 4.384

2.  Customized adherence enhancement for individuals with bipolar disorder receiving antipsychotic therapy.

Authors:  Martha Sajatovic; Jennifer Levin; Curtis Tatsuoka; Weronika Micula-Gondek; Tiffany D Williams; Christopher S Bialko; Kristin A Cassidy
Journal:  Psychiatr Serv       Date:  2012-02-01       Impact factor: 3.084

3.  Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication.

Authors:  Martha Sajatovic; Jennifer Levin; Edna Fuentes-Casiano; Kristin A Cassidy; Curtis Tatsuoka; Janis H Jenkins
Journal:  Compr Psychiatry       Date:  2010-09-01       Impact factor: 3.735

4.  The effect of medication adherence on health care utilization in bipolar disorder.

Authors:  Kim H Lew; Eunice Y Chang; Krithika Rajagopalan; Russell L Knoth
Journal:  Manag Care Interface       Date:  2006-09

5.  Subjective response to neuroleptics in schizophrenia.

Authors:  A G Awad
Journal:  Schizophr Bull       Date:  1993       Impact factor: 9.306

6.  Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder.

Authors:  Martha Sajatovic; Jennifer Levin; Curtis Tatsuoka; Weronika Micula-Gondek; Edna Fuentes-Casiano; Christopher S Bialko; Kristin A Cassidy
Journal:  Bipolar Disord       Date:  2012-05       Impact factor: 6.744

7.  Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review.

Authors:  Marcia Valenstein; Dara Ganoczy; John F McCarthy; Hyungjin Myra Kim; Todd A Lee; Frederic C Blow
Journal:  J Clin Psychiatry       Date:  2006-10       Impact factor: 4.384

8.  Relationships among subjective and objective measures of adherence to oral antipsychotic medications.

Authors:  Dawn I Velligan; Mei Wang; Pamela Diamond; David C Glahn; Desiree Castillo; Scott Bendle; Y W Francis Lam; Larry Ereshefsky; Alexander L Miller
Journal:  Psychiatr Serv       Date:  2007-09       Impact factor: 3.084

Review 9.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

Review 10.  The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.

Authors:  Dawn I Velligan; Peter J Weiden; Martha Sajatovic; Jan Scott; Daniel Carpenter; Ruth Ross; John P Docherty
Journal:  J Clin Psychiatry       Date:  2009       Impact factor: 4.384

View more
  3 in total

1.  Differential Medication Attitudes to Antihypertensive and Mood Stabilizing Agents in response to an Automated Text-Messaging Adherence Enhancement Intervention.

Authors:  Peter Klein; Michelle E Aebi; Martha Sajatovic; Colin Depp; David Moore; Carol Blixen; Jennifer B Levin
Journal:  J Behav Cogn Ther       Date:  2020-07-17

2.  The Relationship Between Medication Attitudes and Medication Adherence Behavior in Adults With Bipolar Disorder.

Authors:  Jennifer B Levin; Michelle E Aebi; Molly Howland; Marina Barboza; Logan Eskew; Curtis Tatsuoka; Kristin A Cassidy; Martha Sajatovic
Journal:  J Nerv Ment Dis       Date:  2020-02       Impact factor: 1.899

Review 3.  Attitudes toward antipsychotic treatment among patients with bipolar disorders and their clinicians: a systematic review.

Authors:  Martha Sajatovic; Faith DiBiasi; Susan N Legacy
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-30       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.